Barometer Capital Management Inc. Has $1.04 Million Holdings in Fresenius Medical Care AG & Co. KGaA $FMS

Barometer Capital Management Inc. increased its holdings in shares of Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) by 569.6% during the first quarter, Holdings Channel.com reports. The fund owned 46,200 shares of the company’s stock after purchasing an additional 39,300 shares during the quarter. Barometer Capital Management Inc.’s holdings in Fresenius Medical Care AG & Co. KGaA were worth $1,042,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Parallel Advisors LLC boosted its holdings in Fresenius Medical Care AG & Co. KGaA by 27.9% in the 1st quarter. Parallel Advisors LLC now owns 4,632 shares of the company’s stock valued at $104,000 after purchasing an additional 1,011 shares during the period. Assetmark Inc. increased its holdings in shares of Fresenius Medical Care AG & Co. KGaA by 190.7% during the first quarter. Assetmark Inc. now owns 132,320 shares of the company’s stock worth $2,985,000 after purchasing an additional 86,798 shares during the period. Advisors Preferred LLC raised its position in shares of Fresenius Medical Care AG & Co. KGaA by 6.1% in the first quarter. Advisors Preferred LLC now owns 10,226 shares of the company’s stock valued at $231,000 after buying an additional 589 shares in the last quarter. Sequoia Financial Advisors LLC acquired a new stake in shares of Fresenius Medical Care AG & Co. KGaA in the first quarter valued at approximately $457,000. Finally, DMC Group LLC raised its position in shares of Fresenius Medical Care AG & Co. KGaA by 15.3% in the first quarter. DMC Group LLC now owns 22,460 shares of the company’s stock valued at $507,000 after buying an additional 2,986 shares in the last quarter. Institutional investors and hedge funds own 8.37% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts recently issued reports on FMS shares. Weiss Ratings downgraded Fresenius Medical Care AG & Co. KGaA from a “hold (c+)” rating to a “hold (c)” rating in a research report on Thursday, May 7th. Morgan Stanley reaffirmed an “underweight” rating on shares of Fresenius Medical Care AG & Co. KGaA in a report on Wednesday, May 6th. Jefferies Financial Group upgraded Fresenius Medical Care AG & Co. KGaA from a “strong sell” rating to a “moderate sell” rating in a research report on Friday, May 8th. Sanford C. Bernstein began coverage on Fresenius Medical Care AG & Co. KGaA in a report on Thursday, July 16th. They set a “market perform” rating on the stock. Finally, Citigroup restated a “neutral” rating on shares of Fresenius Medical Care AG & Co. KGaA in a research report on Friday. Six equities research analysts have rated the stock with a Hold rating and four have issued a Sell rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Reduce” and an average price target of $28.00.

Fresenius Medical Care AG & Co. KGaA Stock Performance

NYSE FMS opened at $24.68 on Wednesday. The firm’s 50 day simple moving average is $22.83 and its 200 day simple moving average is $22.86. The firm has a market capitalization of $13.25 billion, a price-to-earnings ratio of 12.99, a P/E/G ratio of 4.34 and a beta of 0.78. The company has a current ratio of 1.20, a quick ratio of 0.86 and a debt-to-equity ratio of 0.40. Fresenius Medical Care AG & Co. KGaA has a 1 year low of $20.02 and a 1 year high of $27.64.

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) last announced its quarterly earnings data on Tuesday, March 31st. The company reported $1.05 EPS for the quarter. Fresenius Medical Care AG & Co. KGaA had a net margin of 4.88% and a return on equity of 8.90%. The business had revenue of $5.34 billion during the quarter. As a group, research analysts expect that Fresenius Medical Care AG & Co. KGaA will post 2.24 earnings per share for the current fiscal year.

Fresenius Medical Care AG & Co. KGaA Increases Dividend

The firm also recently declared an annual dividend, which was paid on Monday, June 8th. Stockholders of record on Friday, May 22nd were issued a dividend of $0.8716 per share. This is an increase from Fresenius Medical Care AG & Co. KGaA’s previous annual dividend of $0.79. The ex-dividend date of this dividend was Friday, May 22nd. This represents a dividend yield of 402.0%. Fresenius Medical Care AG & Co. KGaA’s payout ratio is presently 32.11%.

Fresenius Medical Care AG & Co. KGaA Company Profile

Fresenius Medical Care AG & Co KGaA is the world’s largest integrated provider of products and services for individuals with renal diseases. The company’s primary business activities encompass the operation of dialysis clinics and the manufacture and distribution of dialysis equipment, dialysis machines, dialyzers, consumables and related therapies. Through its global network of clinics, Fresenius Medical Care delivers comprehensive kidney care, including hemodialysis and peritoneal dialysis treatments, patient education and support services.

In its products segment, the company designs and produces dialysis machines, water treatment systems and disposables such as high‐flux dialyzers and bloodlines.